For those with Hodgkin lymphoma, brentuximab vedotin may increase overall survival

The study’s findings were presented by Stephen Ansell, M.D., Ph.D., at the ASCO Annual Meeting in Chicago in 2022 and were later printed in the New England Journal of Medicine. Hodgkin’s lymphoma is a type of cancer that affects the lymphatic system, which is part of the body’s germ-fighting immune system. The white blood cells […]

Scroll to top